12:00 AM
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

pSivida deal

pSivida said an undisclosed biopharmaceutical company will evaluate its Tethadur protein/antibody delivery technology for...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >